Brady Corporation stock sells French first-aid unit for USD 59 million

Published on 10/07/2026 at 02:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Brady Corporation stock follows a USD 59 million asset sale announced October 1. Fiscal Q4 revenue rose 10.0 percent to USD 436.9 million, while adjusted EPS reached USD 1.48.

BRC, US1046741062, Illustration mit AI erstellt.

Brady Corporation stock is built around a reported USD 59 million sale of its French first-aid business, while the shares closed at USD 85.11 on the NYSE on October 6, 2026. The transaction gives the industrial technology group a fresh portfolio signal after its fiscal Q4 2026 results and Honeywell productivity acquisition.

Brady sells Securimed for USD 59 million

According to TradingView on October 1, 2026, Brady sold Securimed SAS to Safe Life International for reported proceeds of EUR 53 million, or USD 59 million. Securimed supplies customized first-aid kits, healthcare products and emergency-response materials, and Brady said the sale supports its focus on identification and intelligent productivity solutions.

The divestment follows Brady's August 3 completion of the Honeywell Productivity Solutions and Services acquisition, which expands its operating platform. The combination makes portfolio mix and integration execution central to the stock story, while the Securimed sale points in the opposite direction by reducing exposure to a French healthcare-supplies business.

Q4 revenue reaches USD 436.9 million

Brady's fiscal Q4 2026 revenue was USD 436.90 million, up 10.0 percent from the prior-year quarter, and adjusted earnings per share reached USD 1.48 versus USD 1.47 expected. MarketBeat reported these figures from the September 3, 2026 results release and noted that revenue exceeded the USD 427.91 million consensus estimate.

The earnings comparison is important because the quarter delivered both a 10.0 percent sales increase and a USD 0.01 adjusted EPS beat. Brady also set fiscal 2027 adjusted EPS guidance at USD 6.25 to USD 6.75, giving the acquisition a measurable role in the next reporting period.

Consensus target sits above the close

MarketBeat reported a Buy consensus from two analysts and a USD 103.00 average target. That target lies 21.0 percent above the USD 85.11 October 6 NYSE close, making the gap between earnings execution and valuation the key investor question.

Brady's fiscal 2027 guidance implies adjusted EPS growth of 18.1 percent to 27.6 percent against fiscal 2026, according to the same September 3 results context. The range leaves room for integration benefits, but it also places the burden on the combined business to convert scale into earnings while the new portfolio is absorbed.

Stock holds a USD 85.11 close

Brady stock closed at USD 85.11 on the NYSE on October 6, 2026, down 0.35 percent from the prior close of USD 85.41. The session range was USD 84.39 to USD 86.76, the 52-week range was USD 70.57 to USD 99.29, and market capitalization stood at USD 4.0 billion.